Martina Bruniera

Dr. Martina Bruniera

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Giuseppe ReitanoGiuseppe Reitano
Giuseppe Reitano
TCTommaso Ceccato
Tommaso Ceccato
SBSimone Botti
Simone Botti
MBMartina Bruniera
Martina Bruniera
SCSalvatore Carrozza
Salvatore Carrozza
FZFabio Zattoni
Fabio Zattoni
The management of high-risk prostate cancer (PCa) presents a significant clinical challenge, often necessitating treatment intensification due to the potential presence of micrometastases. While radical prostatectomy (RP) constitutes one of the primary treatment modalities, the integration of neoadjuvant and adjuvant therapies suggests a paradigm shift towards more aggressive treatment strategies, also guided by new imaging modalities like positron emission tomography using prostate-specific membrane antigen (PSMA-PET). Despite the benefits, treatment intensification raises concerns regarding increased side effects. This review synthesizes the latest evidence on perioperative treatment intensification and de-escalation for high-risk localized and locally advanced PCa patients eligible for surgery. Through a non-systematic literature review conducted via PubMed, Scopus, Web of Science, and ClinicalTrials.gov, we explored various dimensions of perioperative treatments, including neoadjuvant systemic therapies, adjuvant therapies, and the role of novel diagnostic technologies. Emerging evidence provides more support for neoadjuvant systemic therapies. Preliminary results from studies suggest the potential for treatments traditionally reserved for metastatic PCa to show apparent benefit in a non-metastatic setting. The role of adjuvant treatments remains debated, particularly the use of androgen deprivation therapy (ADT) and adjuvant radiotherapy in patients at higher risk of biochemical recurrence. The potential role of radio-guided PSMA lymph node dissection emerges as a cutting-edge approach, offering a targeted method for eradicating disease with greater precision. Innovations such as artificial intelligence and machine learning are potential game-changers, offering new avenues for personalized treatment and improved prognostication. The intensification of surgical treatment in high-risk PCa patients is a dynamic and evolving field, underscored by the integration of traditional and novel therapeutic approaches. As evidence continues to emerge, these strategies will refine patient selection, enhance treatment efficacy, and mitigate the risk of progression, although with an attentive consideration of the associated side effects.

15 April 2026 in Pediatric Surgery International
Verified
Journal Article
Open access
PDF file
MBMartina Bruniera
Martina Bruniera
GBGiovanni Basso
Giovanni Basso
SBSimone Botti
Simone Botti
MGMartina Grossele
Martina Grossele
MGMichele Gnech
Michele Gnech
AMAlessandro Morlacco
Alessandro Morlacco
Purpose: To evaluate outcomes and complications of different surgical approaches for 10–20 mm internal stones in children, based on bicentric real-world experience. Materials and methods: We retrospectively analysed 96 patients treated between 2009 and 2022 at two tertiary referral centres. Data included demographics, stone characteristics, treatment (extracorporeal shockwave lithotripsy -SWL, retrograde surgery -RIRS, percutaneous nephrolithotomy – PCNL, surgery), complications, and stone-free rates. The primary outcome was stone clearance; complications were graded according to the Clavien-Dindo classification. Categorical variables were compared using Chi-square of Fisher’s exact test. Results: Median age was 61 months (IQR 25–105). Nineteen patients (19.8%) had associated urological conditions. 50% had multiple stones. Treatments included SWL (17.7%), URS/RIRS (46.9%), PCNL (19.8%), and surgery (8.3%). Intraoperative complications occurred in 4.2%, early postoperative in 12.5%, and late complications in 11.5%. Stone clearance after the first procedure was achieved in 47.9%. Clearance rates were 58.8% for SWL, 47.8% for URS/RIRS, and 52.6% for PCNL. No statistically significant differences were observed in stone clearance or complication rates among treatments. Conclusions: All treatments demonstrated safety and efficacy for 10–20 mm pediatric intrarenal stones. Individualized treatment planning, considering stone burden and patient-specific factors, remains essential to optimize outcomes.

30 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
FCFilippo Carletti
Filippo Carletti
Giuseppe ReitanoGiuseppe Reitano
Giuseppe Reitano
ETEleonora Martina Toffoletto
Eleonora Martina Toffoletto
ATArianna Tumminello
Arianna Tumminello
ETElisa Tonet
Elisa Tonet
FZFabio Zattoni
Fabio Zattoni
Background/Objectives: It remains unclear whether certain areas of the prostate are more difficult to accurately sample using MRI/US-fusion-guided freehand single-access transperineal prostate biopsy (FSA-TP). The aim of this study was to evaluate the detection rates of clinically significant (cs) and clinically insignificant (ci) prostate cancer (PCa) in each prostate zone during FSA-TP MRI-target biopsies (MRI-TBs) and systematic biopsies (SB). Methods: This monocentric observational study included a cohort of 277 patients with no prior history of PCa who underwent 3 MRI-TB cores and 14 SB cores with an FSA-TP from January to December 2023. The intraclass correlation coefficient (ICC) was assessed to evaluate the correlation between the Prostate Imaging–Reporting and Data System (PI-RADS) of the index lesion and the International Society of Urological Pathology (ISUP) grade stratified according to prostate zone and region of index lesion at MRI. Multivariate logistic regression analysis was conducted to identify factors associated with PCa and csPCa in patients with discordant results between MRI-TB and SB. Results: FSA-TP-MRI-TB demonstrated higher detection rates of both ciPCa and csPCa in the anterior, apical, and intermediate zones when each of the three MRI-TB cores was analysed separately (p < 0.01). However, when all MRI-TB cores were combined, no significant differences were observed in detection rates across prostate zones (apex, mid, base; p = 0.57) or regions (anterior vs. posterior; p = 0.34). Concordance between radiologic and histopathologic findings, as measured by the intraclass correlation coefficient (ICC), was similar across all zones (apex ICC: 0.33; mid ICC: 0.34; base ICC: 0.38) and regions (anterior ICC: 0.42; posterior ICC: 0.26). Univariate analysis showed that in patients with PCa detected on SB but with negative MRI-TB, older age was the only significant predictor (p = 0.04). Multivariate analysis revealed that patients with PCa detected on MRI-TB but with negative SB, only PSA remained a significant predictor (OR 1.2, 95% CI 1.1–1.4; p = 0.01). In cases with csPCa detected on MRI-TB but with negative SB, age (OR: 1.0, 95% CI 1.0–1.1; p = 0.02), positive digital rectal examination (OR: 2.0, 95% CI 1.1–3.8; p = 0.03), PI-RADS score >3 (OR: 4.5, 95% CI 1.7–12.1; p < 0.01), and larger lesion size (OR: 1.1, 95% CI 1.1–1.2; p < 0.01) were significant predictors. Conclusions: FSA-TP using 14 SB cores and 3 MRI-TB cores ensures comprehensive sampling of all prostate regions, including anterior and apical zones, without significant differences in detection rates between nodules across different zones. Only in a small percentage of patients was csPCa detected exclusively by SB, highlighting the small but important complementary value of combining SB and MRI-TB.

6 June 2026 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
AMAlessandro Morlacco
Alessandro Morlacco
FCFilippo Carletti
Filippo Carletti
ETElisa Tonet
Elisa Tonet
MBMartina Bruniera
Martina Bruniera
MGMartina Grossele
Martina Grossele
FMFabrizio Dal Moro
Fabrizio Dal Moro